10 Cash-Rich Mid Cap Stocks To Buy Now
Cash flow is the money moving in and out of a business over a set period. It is important because it shows how much cash a company actually has on hand, rather than just looking at profits on paper.
Vaxcyte Inc. (PCVX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 8,689,190 | $711,297,093 | 9.46% | |
| 2. | Kynam Capital Derrick Tang | 2,336,796 | $191,290,121 | +125% | 11.3% |
| 3. | Perceptive Advisors Joseph Edelman | 1,718,417 | $140,669,616 | -16% | 3.87% |
| 4. | Commodore Capital Egen Atkinson And Michael Kramarz | 1,625,000 | $133,022,500 | +77% | 9.74% |
| 5. | Maverick Capital Lee Ainslie | 1,201,898 | $98,387,370 | +24% | 1.77% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.00 | 937,500 | Large Shareholder | 5,156,553 | 2020-06-16 | Filing | |
| $16.00 | 12,500 | Director | 4,168,718 | 2020-06-16 | Filing | |
| $16.00 | 93,000 | Director | 2,222,967 | 2020-06-16 | Filing | |
| $16.00 | 250,000 | Director | 2,309,554 | 2020-06-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $72.37 | 112 | Officer | 41,620 | 2025-03-05 | Filing | |
| $71.07 | 2,267 | Officer | 41,732 | 2025-03-05 | Filing | |
| $70.39 | 2,621 | Officer | 43,999 | 2025-03-05 | Filing | |
| $73.84 | 2,085 | Officer | 154,931 | 2025-03-03 | Filing | |
| $73.07 | 5,915 | Officer | 157,016 | 2025-03-03 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 13,091,648 | $1,071,682,283 | 0.06% | |
| 2. | 11,961,687 | $979,183,698 | 0.01% | |
| 3. | 11,106,069 | $909,142,808 | 0.01% | |
| 4. | 10,575,363 | $865,605,331 | 0.43% | |
| 5. | 6,210,523 | $508,393,413 | 0.1% |
News See All
Vaxcyte, Inc. (NASDAQ:PCVX) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, my name is Jess, and I will be your conference operator today.
10 Best Vaccine Stocks to Buy According to Hedge Funds
On February 24, CNBC reported that President Trump declared that sweeping US tariffs on imports from Mexico and Canada “will go forward” in a statement before the expiry of their month-long delay ...
15 Stocks That Will Go to The Moon According to Analysts
While stocks initially fell based on worries regarding Trump tariffs on America’s major trading partners, major indexes recovered from their initial losses as the President delayed tariffs on Mexico...
12 Best Healthcare Stocks to Buy According to Analysts
McKinsey reported that, since 2019, the US healthcare industry witnessed significant financial pressure.
10 Best Russell 2000 Stocks to Invest in According to Analysts
The Russell 2000 Index is a widely followed benchmark that tracks the performance of small-cap companies in the United States.
10 Best Performing Biotech Stocks in 2024
The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and government assistance.
What Makes Vaxcyte (PCVX) An Investment Bet?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” third-quarter 2024 investor letter.
Vaxcyte (PCVX) Surged On Positive Phase 2 Data For Its Drug
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Should You Consider Investing in Vaxcyte (PCVX)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Billionaire Hedge Funds
